Navigation Links
Nonsurgical Therapy Highly Effective for Pain and Infertility in Men

A new research shows that nonsurgical embolization is ninty-eight percent effective, offers a lower recurrence rate and much quicker recovery than surgery// for the treatment of varicoceles (varicose veins in the testicle and scrotum). This condition in men can cause pain, testicular atrophy or fertility problems—and can greatly impact quality of life. “Varicoceles are a major, but underdiagnosed cause of infertility—it is important for these patients to have an early diagnosis and quick management,” said Maurizio Grosso, M.D., interventional radiologist and study author. Statistical analysis of the data from spermiograms showed constant improvement in sperm count, motility, structure and form.

In the research presented today, a liquid alcohol (hydroxypolyethoxydocanol) was used in the procedure to sclerose, or close off, the faulty veins so they can no longer enlarge with blood, alleviating the symptoms. After the outpatient procedure, each patient stayed six hours at the hospital before being discharged. There is an average of one to two days for complete recovery, including resuming physical activity, with embolization. Surgery has a two to three weeks recovery time, with another two to three weeks until the patient can return to full exercise, such as jogging. The interventional radiology treatment is much less painful and does not have the risks associated with general anesthesia.

“This interventional radiology procedure does not require hospitalization or general anesthesia, results are comparable or better than surgery and the recurrence rate is lower,” said Grosso. “The male fertility center at St. Anna Hospital in Turin, which is the largest obstetric and gynecologic hospital in Italy, has recommended the interventional radiology treatment to all varicocele patients for about nine years. Hopefully this research will make American men more aware of their treatment options.” Of the 918 patients treated, only 19 had to be retreated du ring the follow-up period (1999-2006). Fourteen of those who received further treatment required it in the first six months following the procedure. Varicoceles sometimes recur due to the growth of new collateral veins surrounding the treated vessel, or due to incomplete treatment for technical reasons.

This study out of Cuneo, Italy, was conducted over seven years with 918 male patients ranging in age from nine to 65 years-old. During the procedure, the interventional radiologist made a nick in the skin to access the femoral vein, then used X-ray imaging to guide a catheter up the femoral vein into the faulty vein, introducing the alcohol to seal the vein shut and allow healthy veins to take over.


Related medicine news :

1. Nonsurgical Thoracic Aorta Repair Has Much Less Risk of Paralysis Than Surgery
2. Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Consensus on "Combination Therapy" for Breast Cancer
5. Gene Therapy shows promise in treating Hemophilia
6. "Make AIDS Therapy affordable" - Physicians demand
7. Hormone replacement Therapy a headache
8. Simple Therapy
9. Therapy for stopping the spread of cancer cells
10. Gene Therapy Destroys Pancreatic Cancer Cells
11. Letrozole Beats Tamoxifen in Breast Cancer Therapy
Post Your Comments:

(Date:6/27/2016)... , ... June 27, 2016 , ... ... , the only authorized OSHA Training Institute Education Center headquartered in Northern California, ... their workers from extreme heat at their worksites. Employers with workers exposed ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: